PriceTargets.com logo

Praxair - PX Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $10.67
  • Forecasted Upside: 40.44%
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$7.60 As of 04/23/2024 01:00 AM ET
▲ +0.05 (0.66%)
Get New Praxair Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PX

Analyst Price Target is $10.67
▲ +40.44% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Praxair in the last 3 months. The average price target is $10.67, with a high forecast of $15.00 and a low forecast of $9.00. The average price target represents a 40.44% upside from the last price of $7.60.

This chart shows the closing price for PX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 6 investment analysts is to moderate buy stock in Praxair. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
10/31/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
1/29/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
4/29/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
7/28/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
10/26/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
1/24/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
3/24/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
4/23/2024

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/4/2024OppenheimerLower TargetOutperform ➝ Outperform$17.00 ➝ $11.00N/A
3/4/2024Morgan StanleyReiterated RatingOverweight ➝ Equal Weight$12.00 ➝ $9.00N/A
3/4/2024BarclaysLower TargetOverweight ➝ Overweight$14.00 ➝ $9.50N/A
3/1/2024Keefe, Bruyette & WoodsReiterated RatingOutperform ➝ Market Perform$12.00 ➝ $10.00N/A
3/1/2024JPMorgan Chase & Co.Reiterated RatingOverweight ➝ Neutral$15.50 ➝ $9.50N/A
1/24/2024Morgan StanleyLower TargetOverweight ➝ Overweight$13.00 ➝ $12.00N/A
11/13/2023OppenheimerReiterated RatingOutperform ➝ Outperform$15.00N/A
11/10/2023StephensLower TargetOverweight ➝ Overweight$16.00 ➝ $15.00N/A
10/18/2023Morgan StanleyLower TargetOverweight ➝ Overweight$14.00 ➝ $13.00N/A
10/9/2023OppenheimerLower TargetOutperform ➝ Outperform$16.00 ➝ $15.00N/A
8/14/2023Morgan StanleyBoost TargetOverweight ➝ Overweight$13.00 ➝ $14.00N/A
8/14/2023StephensBoost TargetOverweight ➝ Overweight$14.00 ➝ $16.00N/A
8/14/2023BarclaysBoost TargetOverweight ➝ Overweight$14.00 ➝ $15.00N/A
7/19/2023Morgan StanleyReiterated RatingOverweight ➝ Overweight$13.00N/A
4/13/2023OppenheimerBoost TargetOutperform$15.00 ➝ $17.00N/A
3/7/2023Keefe, Bruyette & WoodsLower TargetOutperform$16.00 ➝ $15.00N/A
2/7/2023JPMorgan Chase & Co.Lower TargetOverweight$16.00 ➝ $15.00N/A
1/25/2023OppenheimerBoost TargetOutperform$15.00 ➝ $17.00N/A
1/24/2023Morgan StanleyLower TargetOverweight$15.00 ➝ $14.00N/A
12/19/2022BarclaysLower TargetOverweight$15.00 ➝ $14.00N/A
11/16/2022BarclaysBoost Target$15.00N/A
10/10/2022BarclaysLower TargetOverweight$15.00 ➝ $14.00N/A
8/31/2022BarclaysInitiated CoverageOverweight$15.00N/A
7/19/2022Morgan StanleyLower TargetOverweight$16.00 ➝ $15.00N/A
5/16/2022StephensLower TargetNA$15.00N/A
4/20/2022Morgan StanleyLower TargetOverweight$17.00 ➝ $16.00N/A
4/13/2022OppenheimerLower Target$14.00 ➝ $13.00N/A
11/15/2021StephensInitiated CoverageOverweight$17.00N/A
11/15/2021OppenheimerInitiated CoverageOutperform$20.00N/A
11/15/2021Morgan StanleyInitiated CoverageOverweight$18.00N/A
11/15/2021UBS GroupInitiated CoverageBuy$15.00N/A
11/15/2021Keefe, Bruyette & WoodsInitiated CoverageOutperform$18.00N/A
11/15/2021JPMorgan Chase & Co.Initiated CoverageOverweight$17.00N/A
(Data available from 4/23/2019 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
9/26/2023
  • 3 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/26/2023
  • 4 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/25/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/25/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/24/2024
  • 3 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/23/2024
  • 2 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
3/24/2024
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/23/2024

Current Sentiment

  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Praxair logo
Praxair, Inc. produces and distributes industrial gases. It operates through five segments: North America, Europe, South America, Asia, and Surface Technologies. The company offers atmospheric gases, including oxygen, nitrogen, argon, and rare gases; and process gases, such as carbon dioxide, helium, hydrogen, electronic gases, specialty gases, and acetylene. It also supplies wear-resistant and high-temperature corrosion-resistant metallic and ceramic coatings and powders to the aircraft, energy, printing, primary metals, petrochemical, textile, and other industries. In addition, the company offers electric arc, plasma and wire spray, and high-velocity oxy-fuel equipment; and distributes hardgoods and welding equipment purchased from independent manufacturers. It serves various industries, such as healthcare, petroleum refining, manufacturing, food, beverage carbonation, fiber-optics, steel making, aerospace, chemicals, and water treatment. Praxair, Inc. was founded in 1907 and is headquartered in Danbury, Connecticut.
Read More

Today's Range

Now: $7.60
Low: $7.51
High: $7.66

50 Day Range

MA: $54.84
Low: $3.23
High: $164.50

52 Week Range

Now: $7.60
Low: $140.00
High: $169.75

Volume

597,236 shs

Average Volume

606,086 shs

Market Capitalization

$880.11 million

P/E Ratio

N/A

Dividend Yield

1.74%

Beta

0.52

Frequently Asked Questions

What sell-side analysts currently cover shares of Praxair?

The following Wall Street analysts have issued reports on Praxair in the last twelve months: Barclays PLC, JPMorgan Chase & Co., Keefe, Bruyette & Woods, Morgan Stanley, Oppenheimer Holdings Inc., and Stephens.
View the latest analyst ratings for PX.

What is the current price target for Praxair?

6 Wall Street analysts have set twelve-month price targets for Praxair in the last year. Their average twelve-month price target is $10.67, suggesting a possible upside of 40.4%. Stephens has the highest price target set, predicting PX will reach $15.00 in the next twelve months. Morgan Stanley has the lowest price target set, forecasting a price of $9.00 for Praxair in the next year.
View the latest price targets for PX.

What is the current consensus analyst rating for Praxair?

Praxair currently has 3 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for PX.

What other companies compete with Praxair?

Other companies that are similar to Praxair include BrightSphere Investment Group, Bridge Investment Group, Noah, Abacus Life and Fidus Investment. Learn More about companies similar to Praxair.

How do I contact Praxair's investor relations team?

Praxair's physical mailing address is 10 Riverview Drive, DANBURY CT, 06810. The basic materials company's listed phone number is 203-837-2000 and its investor relations email address is [email protected]. The official website for Praxair is www.praxair.com. Learn More about contacing Praxair investor relations.